Clinical Trials Directory

Trials / Completed

CompletedNCT05279482

Comparison Between Different Doses of Steroids in COVID-19 Patients

Comparison Between Standard Dose Methyl Prednisolone and Megadose Methyl Prednisolone as Regards Outcome in SARS.COV.2 Patients in Intensive Care Unit : Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

aim of this study is to compare between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate, percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit.

Detailed description

Retrospective study for comparison between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate ,percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit. Previous studies suggested that cytokine release syndrome could be involved in the pathophysiology of critical SARS.COV.2 resulting in death so early suppression of cytokine storm may be lifesaving in critical patients.

Conditions

Interventions

TypeNameDescription
OTHERobservation for outcome of methylprednisolone doseno intervention as it is retrospective study for outcome

Timeline

Start date
2022-01-19
Primary completion
2022-03-01
Completion
2022-03-09
First posted
2022-03-15
Last updated
2022-03-15

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05279482. Inclusion in this directory is not an endorsement.